TAMEKA MARTIN: Open Payments
NPI 1740784594 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,695 in 72 payments from 33 companies in 2025. Trend: 2023 $484 · 2024 $80 · 2025 $1,695
Food & beverage: $1,602Education: $93
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $225 |
| Tempus AI, Inc | 3 | $178 |
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| ABBVIE INC. | 3 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Genmab U.S., Inc. | 3 | $88 |
| Daiichi Sankyo Inc. | 3 | $66 |
| Janssen Biotech, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
Products named: XT CDX, LIBTAYO, Nubeqa, IMBRUVICA, Epkinly, IMFINZI, ENHERTU, KISQALI.
Industry payments across TX — which companies pay providers there.
